Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Vaxart, Inc. is a biotechnology company specializing in oral recombinant vaccines using its proprietary VAAST platform. It develops vaccines for infectious diseases like norovirus, COVID-19, influenza, and HPV, emphasizing ease of administration and mucosal immunity. The company focuses on clinical-stage vaccine candidates, leveraging innovative delivery methods, patent protection, and strategic partnerships to address unmet medical needs globally.
This description was generated via AI from an annual report. Updated about 1 year ago.